We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Gene Linked to Lymphatic Abnormalities

By LabMedica International staff writers
Posted on 11 Jul 2013
Genetic analysis and a new lymphatic imaging technique, has shown that the lymphatics are involved in a rare vascular disorder.

When the lymphatics are not functioning, malnutrition, infection and severe edema can ultimately result, which further complicates the diagnosis and treatment of vascular disorders.

Scientists at the University of Texas Health Science Center (Houston, TX, USA) imaged the lymphatics in a patient with a suspected RAS (rat sarcoma) p21 protein activator 1 (RASA1) gene mutation that is known to be linked to Parkes-Weber syndrome (PKWS). More...
This syndrome presents with capillary malformations and arteriovenous fistulas that are associated with abnormal bleeding and heart failure. Imaging techniques included near-infrared fluorescence lymphatic imaging (NIRFLI) developed using military grade night-vision goggle technology.

The investigators used state-of-the-art whole exome sequencing techniques and bioinformatics techniques, and then singled out RASA1 as the only potential causative gene of the disorder in the human research subject. They confirmed the human subject findings in a mouse model developed at the University of Michigan (Ann Arbor, MI, USA). The mouse model not only had a similar RASA1 mutation to the human subject, but a similarly abnormal lymphatic system as imaged by NIRFLI. The team's genetic discovery could be used to identify future pharmacologic strategies to alleviate more common-lymphatic disorders

Eva Sevick-Muraca, PhD, the senior author of the study said, “This study is a game changer. This is a rare case in which we were able to image lymphatic abnormalities in both a patient and a mouse model that harbored similar mutations known only to be associated with vascular malformations. The striking results underscore the potential role of the lymphatics in vascular disorders." The study was published on May 21, 2013, in the journal Proceedings of the National Academy of Sciences of the Unites States of America (PNAS).

Related Links:
University of Texas Health Science Center
University of Michigan



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Pipette Controller
Sapphire MaxiPette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.